UAE elected to UN Commission on Narcotic Drugs as Asia-Pacific representative
UAE strengthens international role in shaping global drug policies and enhancing regional security

UAE Elected to UN Commission on Narcotic Drugs, Representing Asia-Pacific for 2026–2029
Strengthening Global Role in Drug Policy and International Security
ABU DHABI, April 6: The United Arab Emirates has been elected to the United Nations Commission on Narcotic Drugs (CND) for the term 2026 to 2029, securing a key seat as a representative of the Asia-Pacific Group. The election was held at the United Nations Headquarters in New York and represents an important milestone in the UAE’s growing influence in global policymaking.
The UAE’s Ministry of Interior spearheaded the successful candidacy, demonstrating the country’s strong diplomatic presence and commitment to tackle global drug concerns through international cooperation.
CND’s Global Mandate Explained
The Commission on Narcotic Drugs is the main policymaking body within the UN system for drug control. It was established in 1946 under ECOSOC Resolution No. 9, and its responsibilities have since grown. In 1991, the UN General Assembly expanded its mandate to also serve as the governing body of the UN Office on Drugs and Crime (UNODC).
As a member of the Commission, the UAE will now actively participate in creating global drug control policies, including overseeing international treaty implementation, proposing new policy frameworks, and voting on crucial resolutions.
A Regional Leader With a Global Voice
By joining Pakistan, Kazakhstan, and Kyrgyzstan on the Commission, the UAE bolsters its position as a regional leader with global reach. This appointment signifies the UAE’s commitment to implementing integrated, coordinated drug-reduction strategies, enhancing international security, and ensuring a balanced global drug policy.
The accession comes as CND works to implement the 2019 Ministerial Declaration, which outlined global commitments to accelerate the fight against the global drug crisis. A midterm assessment was done in 2024, with a full progress review set for 2029, the year the UAE’s new term ends.
Through this appointment, the UAE will play a hands-on role in tackling drug-related issues on a global scale—working closely with UN member states to analyze drug trends, shape policy, and promote a sustainable, secure future for communities worldwide.
This recognition is a testament to the UAE’s growing international stature and its enduring efforts in multilateral diplomacy, drug control, and public safety.



